Veltuzumab is a monoclonal antibody which is being investigated for the treatment of non-Hodgkin’s lymphoma. As of December 2011 it is undergoing Phase I/II clinical trials.This drug was developed by […]
List of articles in "Drug" category - Page 205
Tigatuzumab
Tigatuzumab (CS-1008) is a monoclonal antibody for the treatment of cancer.
Milatuzumab
Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma and other hematological malignancies.This drug was developed by Immunomedics Inc.It has been linked to doxorubicin to form an antibody-drug […]
Farletuzumab
Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.This drug was developed by Morphotek Inc.It is targeted at FR-alpha which is overexpressed in […]
Citatuzumab bogatox
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin an ribosome inactivating protein from the plant Bougainvillea spectabilis. It has undergone pre-clinical trials for the treatment of […]
Obinutuzumab
Obinutuzumab (called afutuzumab until 2009) is a humanized monoclonal antibody originated by Glycart Biotechnology AG and developed by Biogen Idec Chugai Pharmaceutical Co. and Hoffmann-La Roche Inc. for the treatment […]
Tenatumomab
Tenatumomab is a monoclonal antibody designed for the treatment of cancer.
Ramucirumab
Ramucirumab (IMC-1121B trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. It is directed against the vascular endothelial growth factor receptor 2 […]
Rafivirumab
Rafivirumab is a monoclonal antibody for the prophylaxis of rabies.
Foravirumab
Foravirumab is a monoclonal antibody for the prophylaxis of rabies.